Merav Bar
Bristol-Myers Squibb (Germany)
ORCID: 0009-0007-9370-9201Also affiliated with Medical University of Silesia, Fred Hutch Cancer Center, Bristol-Myers Squibb (United States), Bristol-Myers Squibb (Switzerland)
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 4 papers. Top paper: “Factors associated with outcomes after a second CD19-targeted CAR T-cell infusion for refractory B-cell malignancies”.
Evandro D. Bezerra, Alexandre V. Hirayama, Salvatore Fiorenza, Alyssa Sheih, Cassie K. Chou +20 more
Hamza Hashmi, Mahmoud Elsawy, Soyoung Kim, Amy Moskop, Temitope Oloyede +40 more
Elizabeth M. Krantz, Joyce Maalouf, Jim Boonyaratanakornkit, Jacob Keane-Candib, Laurel Joncas-Schronce +13 more
L. Martin, Daniel Egan, Merav Bar, Sinéad Kinsella, Kelly G. Paulson +19 more